Contraception
635
36
52
466
Key Insights
Highlights
Success Rate
94% trial completion (above average)
Published Results
172 trials with published results (27%)
Research Maturity
466 completed trials (73% of total)
Clinical Risk Assessment
Based on trial outcomes
Moderate Risk
Score: 30/100
5.0%
32 terminated out of 635 trials
93.6%
+7.0% vs benchmark
28%
178 trials in Phase 3/4
37%
172 of 466 completed with results
Key Signals
Data Visualizations
Phase Distribution
Trial Status
Trial Success Rate
Benchmark: 86.6%
Based on 466 completed trials
Clinical Trials (635)
Long Term Evaluation of Scapular-inserted Contraceptive Implants
Pharmacokinetic Study of Long-acting Antiretrovirals and Contraceptives in HIV
Evaluation of the Safety and Efficacy of the ReLARC Inserter During the Insertion Procedure of GYNEFIX Intrauterine Copper Bearing Contraceptive Device With a Follow-up of 3 Years.
Study of the Safety and Efficacy of MR-100A-01 in Approximately 1200 Healthy Women for up to 13 Cycles
Prospective Multi-Center Trial for FemBloc Permanent Birth Control
Pilot Bi-Lateral Tubal Occlusion Trial for Female Permanent Contraception
DYnamic decisioN Support for IntegrAting PrEP in Clinics for Young People in Alabama and Botswana
Intervening on Women's Health for Rural Young Cancer Survivors
The HOP-STEP Intervention: Improving Maternal Health in Women With Lupus sIRB
A Study to Assess the Safety of a New Inserter Device for Paragard® (Intrauterine Copper Contraceptive)
Project for Reproductive Equity Through Volunteers and Entrepreneurship, Networks and Technology
Etonogestrel Implant as Emergency Contraception
A 3-way Crossover Clinical Investigation to Assess the Performance of Two Different Sized Polyurethane Condoms Versus a Latex Condom in Healthy Monogamous Couples.
Trial of the "Mittin" Intervention to Improve Contraceptive Side Effect Counseling and Follow-up in Ethiopia
"Vasectomy: Right for Me?" Decision Support Tool
I-CAN Uganda Effectiveness Trial
Evaluation of the Contraceptive Efficacy and Safety of a New Concentration of an Antiandrogenic Progestogen Combined With a Reduced-Dose Estrogen (LUNA)
Oral Contraceptive Pill (OCP) Pharmacogenomics
Validation of Effectiveness on NaturalCycles Users
Safety of a Contraceptive Copper Vaginal Ring